Medetomidine BSA conjugate

The Medetomidine-BSA conjugate is a synthetic immunogen designed for the generation of antibodies against medetomidine, a selective alpha2-adrenergic receptor agonist commonly used in veterinary anesthesia and research. Due to its low molecular weight and limited immunogenicity, medetomidine must be conjugated to a carrier protein to elicit a robust immune response. In this construct, medetomidine is covalently linked to bovine serum albumin (BSA) via a chemically defined linker, ensuring stable attachment while preserving the pharmacologically relevant epitope. This conjugate is suitable for applications in antibody production and the development of immunoassays such as ELISA, competitive binding assays, and lateral flow devices for the qualitative or quantitative detection of medetomidine or structurally related compounds. This reagent is intended for research use only and is not approved for diagnostic or therapeutic applications.